Dosing Protocols for BPC-157 and TB-500

Introduction

Proper dosing is critical for achieving desired outcomes with BPC-157 and TB-500 while minimizing potential risks. This guide provides comprehensive dosing information based on available research and practitioner experience.

BPC-157 Dosing

Standard Dosing Range

• Conservative: 200-250 mcg per day
• Moderate: 250-500 mcg per day
• Aggressive: 500-750 mcg per day (rarely needed)

Administration Methods

Timing Considerations

• Morning and evening dosing for split protocols
• Can be taken with or without food
• Consistent timing recommended
• Duration: 4-12 weeks typically

TB-500 Dosing

Loading Phase (Weeks 1-6)

• Standard: 2.0-2.5 mg twice weekly
• Total weekly dose: 4-5 mg
• Purpose: Achieve therapeutic tissue levels

Maintenance Phase (After Loading)

• Standard: 2.0-2.5 mg once weekly
• Or: 1.0-1.25 mg twice weekly
• Duration: As needed for recovery

Administration

• Subcutaneous injection most common
• Reconstitute with bacteriostatic water
• Can inject anywhere (not site-specific)
• Store reconstituted solution refrigerated

Combined Protocol Example

Reconstitution Guidelines

BPC-157

• Add 2ml bacteriostatic water to 5mg vial
• Concentration: 2,500 mcg/ml
• 10 units on insulin syringe = 250 mcg

TB-500

• Add 2ml bacteriostatic water to 5mg vial
• Concentration: 2,500 mcg/ml
• 100 units (1ml) = 2.5 mg

Safety Notes

• Start conservative and titrate up
• Monitor for unusual reactions
• Proper sterile technique essential
• Quality sourcing critical for accurate dosing

Conclusion

Individualized dosing based on goals, body weight, and response is ideal. These protocols provide a framework that can be adjusted based on individual needs.

Comparison table